| Stage | NVDA | % of rev | ON | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $1.7B | 100.00% | NVDA ×55.87 |
| Gross profit | $72.1B | 74.98% | $713M | 41.40% | NVDA +33.6pp |
| Operating income | $63.7B | 66.24% | $378M | 21.96% | NVDA +44.3pp |
| Pre-tax income | $71.5B | 74.32% | $399M | 23.18% | NVDA +51.1pp |
| Net income | $59.7B | 62.03% | $314M | 18.25% | NVDA +43.8pp |
| Stage | NVDA | ON | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $1.7B100.00% | NVDA ×55.87 |
| Gross profit | 74.98%$72.1B | 41.40%$713M | NVDA +33.6pp |
| Operating income | 66.24%$63.7B | 21.96%$378M | NVDA +44.3pp |
| Pre-tax income | 74.32%$71.5B | 23.18%$399M | NVDA +51.1pp |
| Net income |
| 62.03%$59.7B |
| 18.25%$314M |
| NVDA +43.8pp |
No shared counterparties.